OrthoPediatrics (KIDS) Short Interest Ratio & Short Volume $22.76 +0.88 (+4.02%) Closing price 07/22/2025 04:00 PM EasternExtended Trading$22.76 0.00 (0.00%) As of 07/22/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OrthoPediatrics Short Interest DataOrthoPediatrics (KIDS) has a short interest of 1.06 million shares, representing 6.47% of the float (the number of shares available for trading by the public). This marks a -3.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.5, indicating that it would take 7.5 days of the average trading volume of 197,473 shares to cover all short positions.Current Short Interest1,060,000 sharesPrevious Short Interest1,100,000 sharesChange Vs. Previous Month-3.64%Dollar Volume Sold Short$22.77 millionShort Interest Ratio7.5 Days to CoverLast Record DateJune 30, 2025Outstanding Shares24,290,000 sharesFloat Size16,390,000 sharesShort Percent of Float6.47%Today's Trading Volume177,611 sharesAverage Trading Volume197,473 sharesToday's Volume Vs. Average90% Short Selling OrthoPediatrics? Sign up to receive the latest short interest report for OrthoPediatrics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKIDS Short Interest Over TimeKIDS Days to Cover Over TimeKIDS Percentage of Float Shorted Over Time OrthoPediatrics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20251,060,000 shares $22.77 million -3.6%6.5%7.5 $21.48 6/15/20251,100,000 shares $23.28 million -0.9%6.7%7.6 $21.16 5/31/20251,110,000 shares $22.39 million -3.5%6.8%7.5 $20.17 5/15/20251,150,000 shares $26.30 million -0.9%7.0%6.7 $22.87 4/30/20251,160,000 shares $24.15 million +3.6%7.1%5.6 $20.82 4/15/20251,120,000 shares $23.49 million +9.8%6.8%4.8 $20.97 3/31/20251,020,000 shares $25.12 million -8.1%6.2%3.8 $24.63 3/15/20251,110,000 shares $27.84 million +13.9%6.9%3.9 $25.08 2/28/2025974,300 shares $22.62 million +4.8%5.9%3.1 $23.22 2/15/2025930,100 shares $22.90 million +12.6%5.7%3.3 $24.62 Get the Latest News and Ratings for KIDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025826,300 shares $19.83 million -9.7%5.1%3 $24.00 1/15/2025914,900 shares $23.86 million +0.3%5.6%3.8 $26.08 12/31/2024912,100 shares $21.14 million +10.9%5.6%4.3 $23.18 12/15/2024822,400 shares $18.19 million -6.5%5.0%4.2 $22.12 11/30/2024879,400 shares $22.85 million +9.8%5.4%5.2 $25.98 11/15/2024801,100 shares $18.37 million -12.3%4.9%4.9 $22.93 10/31/2024913,900 shares $24.25 million -1.7%5.6%5.7 $26.53 10/15/2024929,600 shares $25.13 million -3.3%5.7%5.4 $27.03 9/30/2024961,700 shares $26.07 million +13.2%5.9%5.4 $27.11 9/15/2024849,900 shares $27.43 million -8.9%5.2%4.8 $32.28 8/31/2024932,500 shares $29.79 million +6.2%5.7%5.5 $31.95 8/15/2024878,400 shares $24.28 million +3.0%5.4%5.3 $27.64 7/31/2024853,000 shares $26.26 million -18.0%5.3%5.6 $30.78 7/15/20241,040,000 shares $34.20 million -1.0%6.5%7.4 $32.88 6/30/20241,050,000 shares $30.20 million +1.0%6.6%7.2 $28.76 6/15/20241,040,000 shares $30.47 million -5.5%6.5%7.2 $29.30 5/31/20241,100,000 shares $34.74 million -5.2%6.8%7.3 $31.58 5/15/20241,160,000 shares $36.39 million +5.5%7.1%6.9 $31.37 4/30/20241,100,000 shares $32.59 million +11.9%6.8%6.4 $29.63 4/15/2024982,700 shares $29.92 million -5.5%6.1%5.6 $30.45 3/31/20241,040,000 shares $30.33 million +10.5%6.6%5.8 $29.16 3/15/2024941,200 shares $23.52 million +9.9%5.9%5.3 $24.99 2/29/2024856,800 shares $23.53 million 0.0%5.4%5 $27.46 2/15/2024856,900 shares $25.34 million +3.3%5.4%5.4 $29.57 1/31/2024829,700 shares $21.67 million -16.0%5.3%5 $26.12 1/15/2024987,600 shares $28.30 million -4.1%6.3%6 $28.66 12/31/20231,030,000 shares $33.49 million +13.1%6.5%6.3 $32.51 12/15/2023910,900 shares $28.38 million -2.8%5.8%5.8 $31.16 11/30/2023937,400 shares $28.90 million -18.5%6.0%6.4 $30.83 11/15/20231,150,000 shares $35.43 million -12.9%7.3%8.4 $30.81Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 10/31/20231,320,000 shares $32.29 million -2.9%8.4%10.3 $24.46 10/15/20231,360,000 shares $32.93 million +4.6%8.7%11.6 $24.21 9/30/20231,300,000 shares $41.60 million No Change8.3%13.8 $32.00 9/15/20231,300,000 shares $44.29 million -0.8%8.3%15.7 $34.07 8/31/20231,310,000 shares $50.07 million +4.8%8.3%15.4 $38.22 8/15/20231,250,000 shares $48.49 million +6.8%8.0%14.6 $38.79 7/31/20231,170,000 shares $48.85 million No Change7.4%13.2 $41.75 7/15/20231,170,000 shares $51.95 million +7.3%7.5%13.6 $44.40 6/30/20231,090,000 shares $47.80 million +0.9%6.9%12.4 $43.85 6/15/20231,080,000 shares $51.20 million -1.8%6.9%11.5 $47.41 5/31/20231,100,000 shares $47.52 million +0.9%7.1%11.1 $43.20 5/15/20231,090,000 shares $48.21 million -2.7%7.0%9.6 $44.23 4/30/20231,120,000 shares $56.49 million -2.6%7.2%9.9 $50.44 4/15/20231,150,000 shares $55.66 million -2.5%7.5%10.2 $48.40 3/31/20231,180,000 shares $52.26 million +1.7%7.7%9.7 $44.29 3/15/20231,160,000 shares $48.13 million +4.5%7.6%9.1 $41.49 2/28/20231,110,000 shares $48.57 million +3.7%7.2%8.4 $43.76 2/15/20231,070,000 shares $49.04 million -5.3%7.0%8.6 $45.83 1/31/20231,130,000 shares $53.26 million -18.1%7.4%9.1 $47.13 1/15/20231,380,000 shares $62.29 million -11.0%9.0%10.2 $45.14 12/30/20221,550,000 shares $61.58 million -3.1%10.1%11.5 $39.73 12/15/20221,600,000 shares $60.72 million No Change10.4%13.4 $37.95 11/30/20221,600,000 shares $70.38 million -8.1%11.1%14.4 $43.99 11/15/20221,740,000 shares $78.20 million +0.6%12.1%16.4 $44.94 10/31/20221,730,000 shares $73.51 million +1.2%12.0%15.2 $42.49 10/15/20221,710,000 shares $71.96 million -2.3%13.4%16.8 $42.08 9/30/20221,750,000 shares $80.75 million +1.2%13.7%16.3 $46.14 9/15/20221,730,000 shares $86.43 million +4.9%13.6%15.6 $49.96 8/31/20221,650,000 shares $81.00 million No Change11.6%14.3 $49.09 8/15/20221,650,000 shares $93.51 million -16.7%11.6%14.6 $56.67 7/31/20221,980,000 shares $93.56 million +0.5%13.9%17.3 $47.25 7/15/20221,970,000 shares $82.98 million +3.1%13.8%17.2 $42.12 6/30/20221,910,000 shares $82.42 million +6.1%13.4%16.5 $43.15 6/15/20221,800,000 shares $72.76 million +5.3%12.7%15.6 $40.42 5/31/20221,710,000 shares $78.95 million No Change12.0%15 $46.17 5/15/20221,710,000 shares $72.01 million -1.7%12.0%13 $42.11 4/30/20221,740,000 shares $78.44 million +5.5%12.4%13.5 $45.08 4/15/20221,650,000 shares $80.44 million +23.1%11.7%14.1 $48.75 3/31/20221,340,000 shares $72.35 million +6.4%9.8%11.8 $53.99 3/15/20221,260,000 shares $57.61 million +5.0%9.2%12.1 $45.72 2/28/20221,200,000 shares $67.26 million -4.8%8.7%11.7 $56.05 2/15/20221,260,000 shares $64.11 million +8.6%9.2%14.3 $50.88 1/31/20221,160,000 shares $54.86 million -10.1%8.4%13.9 $47.29 1/15/20221,290,000 shares $68.90 million -5.2%9.4%15.8 $53.41 12/31/20211,360,000 shares $81.41 million -1.5%9.9%17 $59.86 12/15/20211,380,000 shares $79.06 million -6.1%10.0%17.2 $57.29 11/30/20211,470,000 shares $81.89 million +7.3%10.7%18.4 $55.71 11/15/20211,370,000 shares $87.21 million -9.3%10.0%17.8 $63.66 10/29/20211,510,000 shares $107.47 million -3.8%11.0%19 $71.17 10/15/20211,570,000 shares $98.80 million +0.6%11.4%19.4 $62.93Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 9/30/20211,560,000 shares $102.20 million -4.9%11.3%19.9 $65.51 9/15/20211,640,000 shares $113.82 million -0.6%11.9%19.8 $69.40 8/31/20211,650,000 shares $115.67 million +0.6%12.0%19.9 $70.10 8/13/20211,640,000 shares $103.93 million -5.8%11.9%18.7 $63.37 7/30/20211,740,000 shares $109.34 million -1.1%12.7%19.1 $62.84 7/15/20211,760,000 shares $101.99 million -2.2%12.9%15.9 $57.95 6/30/20211,800,000 shares $113.72 million -4.3%13.1%15.5 $63.18 6/15/20211,880,000 shares $118.83 million +2.7%13.7%14.5 $63.21 5/28/20211,830,000 shares $103.38 million +1.1%13.4%12 $56.49 5/14/20211,810,000 shares $101.40 million -13.8%13.2%10.7 $56.02 4/30/20212,100,000 shares $120.16 million +10.0%15.3%11.5 $57.22 4/15/20211,910,000 shares $94.43 million -0.5%14.0%9.6 $49.44 3/31/20211,920,000 shares $90.26 million +6.7%14.0%9.3 $47.01 3/15/20211,800,000 shares $82.96 million +2.9%13.2%8.3 $46.09 2/26/20211,750,000 shares $95.59 million -2.8%12.9%8 $54.62 2/12/20211,800,000 shares $91.03 million -20.7%13.2%8.2 $50.57 1/29/20212,270,000 shares $106.76 million -15.6%16.7%10.3 $47.03 1/15/20212,690,000 shares $110.48 million -5.6%19.8%12.5 $41.07 12/31/20202,850,000 shares $124.17 million -5.6%21.0%15 $43.57 12/15/20203,020,000 shares $130.16 million +3.4%22.2%16.4 $43.10 11/30/20202,920,000 shares $137.18 million +1.7%21.5%15.5 $46.98 11/15/20202,870,000 shares $134.29 million +1.8%21.1%17.5 $46.79 10/30/20202,820,000 shares $125.12 million -2.1%20.8%17.4 $44.37 10/15/20202,880,000 shares $135.85 million +8.3%21.2%19.1 $47.17 9/30/20202,660,000 shares $122.15 million +14.7%19.6%17.5 $45.92 9/15/20202,320,000 shares $104.89 million +37.3%17.1%15.2 $45.21 8/31/20201,690,000 shares $85.18 million -1.7%12.5%10.3 $50.40 8/14/20201,720,000 shares $89.42 million -16.1%12.7%11.5 $51.99 7/31/20202,050,000 shares $86.49 million +14.5%15.1%13.9 $42.19 KIDS Short Interest - Frequently Asked Questions What is OrthoPediatrics' current short interest? Short interest is the volume of OrthoPediatrics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 1,060,000 shares of KIDS short. 6.47% of OrthoPediatrics' shares are currently sold short. Learn More on OrthoPediatrics' current short interest. What is a good short interest ratio for OrthoPediatrics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KIDS shares currently have a short interest ratio of 8.0. Learn More on OrthoPediatrics's short interest ratio. What is a good short interest percentage for OrthoPediatrics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.47% of OrthoPediatrics' floating shares are currently sold short. Is OrthoPediatrics' short interest increasing or decreasing? OrthoPediatrics saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 1,060,000 shares, a decrease of 3.6% from the previous total of 1,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OrthoPediatrics' float size? OrthoPediatrics currently has issued a total of 24,287,000 shares. Some of OrthoPediatrics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OrthoPediatrics currently has a public float of 16,390,000 shares. How does OrthoPediatrics' short interest compare to its competitors? 6.47% of OrthoPediatrics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to OrthoPediatrics: National Vision Holdings, Inc. (9.39%), NovoCure Limited (5.29%), LeMaitre Vascular, Inc. (7.14%), Enovis Corporation (14.18%), CONMED Corporation (7.57%), Cadre Holdings, Inc. (6.37%), Artivion, Inc. (3.59%), Establishment Labs Holdings Inc. (18.01%), Liquidia Technologies, Inc. (33.98%), Paragon 28, Inc. (2.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), Strategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short OrthoPediatrics stock? Short selling KIDS is an investing strategy that aims to generate trading profit from OrthoPediatrics as its price is falling. KIDS shares are trading up $0.88 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OrthoPediatrics? A short squeeze for OrthoPediatrics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KIDS, which in turn drives the price of the stock up even further. How often is OrthoPediatrics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KIDS, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies National Vision Short Squeeze NovoCure Short Squeeze LeMaitre Vascular Short Squeeze Enovis Short Squeeze CONMED Short Squeeze Cadre Short Squeeze Artivion Short Squeeze Establishment Labs Short Squeeze Liquidia Technologies Short Squeeze Paragon 28 Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KIDS) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
